Northern Trust’s Faeth Therapeutics FTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,299
Closed -$10.2K 4486
2025
Q1
$10.2K Hold
1,299
﹤0.01% 4385
2024
Q4
$12.7K Hold
1,299
﹤0.01% 4410
2024
Q3
$15.5K Hold
1,299
﹤0.01% 4355
2024
Q2
$16.1K Sell
1,299
-3
-0.2% -$62 ﹤0.01% 4347
2024
Q1
$27.4K Hold
1,302
﹤0.01% 4304
2023
Q4
$18K Hold
1,302
﹤0.01% 4377
2023
Q3
$20.8K Hold
1,302
﹤0.01% 4324
2023
Q2
$29.7K Hold
1,302
﹤0.01% 4328
2023
Q1
$39.1K Hold
1,302
﹤0.01% 4317
2022
Q4
$38.8K Hold
1,302
﹤0.01% 4344
2022
Q3
$40K Buy
1,302
+525
+68% +$20.6K ﹤0.01% 4385
2022
Q2
$35K Sell
777
-6,931
-90% -$260K ﹤0.01% 4510
2022
Q1
$356K Sell
7,708
-285
-4% -$22.7K ﹤0.01% 3876
2021
Q4
$928K Sell
7,993
-45
-0.6% -$6.72K ﹤0.01% 3571
2021
Q3
$1.69M Buy
8,038
+4,287
+114% +$780K ﹤0.01% 3366
2021
Q2
$733K Sell
3,751
-346
-8% -$85.5K ﹤0.01% 3603
2021
Q1
$1.19M Buy
+4,097
New +$1.37M ﹤0.01% 3512

Other funds holding FTH

Northern Trust's FTH Position: Q2 2025 in Review

Northern Trust sold out of Faeth Therapeutics (FTH) in Q2 2025, closing a stake of 1,299 shares — an estimated $10.2K sold.

Northern Trust first reported a position in FTH in Q1 2021 and held it in 17 quarters. The position peaked at $1.69M in Q3 2021. 10 funds tracked by Wall St. Rank hold FTH as of Q2 2025.

  • Northern Trust reported no remaining Faeth Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 1,299 Faeth Therapeutics shares in Q2 2025, an estimated $10.2K.
  • Northern Trust first reported a position in Faeth Therapeutics in Q1 2021 and held it in 17 quarters.
  • Northern Trust's Faeth Therapeutics position peaked at $1.69M in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.